Chemcrux Enterprises Limited
Chemcrux Enterprises Limited (CHEMCRUX) financial statements and selected valuation metrics from NSE/BSE exchange filings through 31 December 2025.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
chemcrux.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-01
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 19 Cr | 17 Cr | 18 Cr | 19 Cr | 16 Cr | 17 Cr | 18 Cr | 22 Cr |
| Operating expenses (approx.) | 16 Cr | 15 Cr | 15 Cr | 17 Cr | 14 Cr | 15 Cr | 16 Cr | 19 Cr |
| EBITDA | 3 Cr | 2 Cr | 2 Cr | 3 Cr | 2 Cr | 2 Cr | 2 Cr | 4 Cr |
| OPM % | 14.2% | 12.1% | 13.3% | 13.9% | 13.4% | 9.8% | 10.1% | 16.0% |
| Other income | 0.35 Cr | 0.39 Cr | 0.26 Cr | 0.61 Cr | 0.24 Cr | 0.44 Cr | 0.63 Cr | 0.60 Cr |
| Interest | 0.13 Cr | 0.13 Cr | 0.33 Cr | 0.60 Cr | 0.69 Cr | 0.86 Cr | 0.83 Cr | 0.76 Cr |
| Depreciation | 0.55 Cr | 0.56 Cr | 0.73 Cr | 0.92 Cr | 0.99 Cr | 1 Cr | 1 Cr | 1 Cr |
| Profit before tax | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 0.67 Cr | 0.03 Cr | 0.40 Cr | 2 Cr |
| Tax % | 3.6% | 29.7% | 26.3% | 25.6% | 69.1% | -200.0% | 46.2% | 27.9% |
| Net profit | 2 Cr | 1 Cr | 1 Cr | 1 Cr | 0.21 Cr | 0.09 Cr | 0.21 Cr | 2 Cr |
| EPS (₹) | ₹1.49 | ₹0.84 | ₹0.77 | ₹0.89 | ₹0.14 | ₹0.06 | ₹0.14 | ₹1.06 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|
| Sales | 78 Cr | 70 Cr | Sign in for TTM |
| Operating expenses (approx.) | 65 Cr | 61 Cr | Sign in for TTM |
| EBITDA | 13 Cr | 9 Cr | Sign in for TTM |
| OPM % | 16.8% | 13.2% | Sign in for TTM |
| Other income | 1 Cr | 1 Cr | Sign in for TTM |
| Interest | 0.83 Cr | 2 Cr | Sign in for TTM |
| Depreciation | 2 Cr | 3 Cr | Sign in for TTM |
| Profit before tax | 11 Cr | 6 Cr | Sign in for TTM |
| Tax % | 26.1% | 32.1% | Sign in for TTM |
| Net profit | 8 Cr | 4 Cr | Sign in for TTM |
| EPS (₹) | ₹5.70 | ₹2.64 | Sign in for TTM |
| Dividend payout % | 35.1% | 37.8% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| Equity capital | 15 Cr | 15 Cr |
| Reserves | 57 Cr | 60 Cr |
| Borrowings | 26 Cr | 42 Cr |
| Other liabilities | 12 Cr | 11 Cr |
| Total liabilities | 110 Cr | 127 Cr |
| Fixed assets (net) | 32 Cr | 76 Cr |
| CWIP | 21 Cr | 2 Cr |
| Investments | 21 Cr | 21 Cr |
| Inventories | 8 Cr | 10 Cr |
| Trade receivables | 15 Cr | 12 Cr |
| Cash & bank | 0.08 Cr | 1 Cr |
| Other assets | 13 Cr | 6 Cr |
| Total assets | 110 Cr | 127 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| Cash from operating activity | 17 Cr | 8 Cr |
| Cash from investing | -26 Cr | -2 Cr |
| Cash from financing | 7 Cr | -9 Cr |
| Net cash flow | -2 Cr | -4 Cr |
| Free cash flow (OCF − Capex) | -8 Cr | -0.80 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| ROCE % | 12.5% | 6.5% |
| ROE % | 11.7% | 0.0% |
| Debtor days | 71 | 61 |
| Inventory days | 121 | 122 |
| Days payable | 101 | 55 |
| Cash conversion cycle | 91 | 129 |
| Debt / equity | 0.35 | 0.56 |
| Current ratio | 3.88 | 2.31 |
| Net debt / EBITDA | 1.93 | 4.39 |
Compare with peers
Loading peers…